This page contains brief information about binimetinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
FDA label information for this drug is available at DailyMed.
Use in Cancer
Binimetinib is approved to be used with encorafenib to treat:
- Melanoma that cannot be removed by surgery or has metastasized (spread to other parts of the body). It is used in patients whose disease has a certain mutation in the BRAF gene.
Binimetinib is also being studied in the treatment of other types of cancer.
More About Binimetinib
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Binimetinib – Check for trials from TCH’s list of cancer clinical trials now accepting patients.